Recent advances in the discovery of novel anti-herpetic agents from Chinese herbal medicines

Current Organic Chemistry

Volumn 14, Issue 16, 2010, Pages 1714-1726

  Cheng, C L ^a   Ng, K Y ^a   Xu, H X ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese herbal medicines; Herpes simplex virus; HSV 1; HSV 2; Microbicides; Structural modification

Indexed keywords

CHEMICAL MODIFICATION; MEDICINE; PLANT EXTRACTS;

CHINESE HERBAL MEDICINES; CHINESE HERBS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; LIGNANS; MICROBICIDES; NOVEL MOLECULES; STRUCTURAL MODIFICATIONS; VIRUS INFECTION;

VIRUSES;

EID: 78649939269     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527210792927690     Document Type: Article

References (90)

1. Xu, F.; Sternberg, M. R.; Kottiri, B. J.; McQuillan, G. M.; Lee, F. K.; Nahmias, A. J.; Berman, S. M.; Markowitz, L. E., Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296 (8), 964-973.
2. Kimberlin, D. Herpes simplex virus, meningitis and encephalitis in neonates. Herpes 2004, 11 (Suppl 2), 65A-76A.
3. Whitley, R. J.; Kimberlin, D. W.; Roizman, B. Herpes simplex viruses. Clin. Infect. Dis., 1998, 26 (3), 541-553; quiz 554-555.
4. Bhattarakosol, P.; Visaprom, S.; Sangdara, A.; Mungmee, V. Increase of genital HSV-1 and mixed HSV-1 and HSV-2 infection in Bangkok, Thailand. J. Med. Assoc. Thai., 2005, 88 (Suppl 4), S300-S304.
5. Cunningham, A. L.; Taylor, R.; Taylor, J.; Marks, C.; Shaw, J.; Mindel, A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex. Transm. Infect., 2006, 82 (2), 164-168.
6. Doi, Y.; Ninomiya, T.; Hata, J.; Yonemoto, K.; Tanizaki, Y.; Arima, H.; Liu, Y.; Rahman, M.; Iida M.,Kiyohara, Y. Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan. J. Epidemiol., 2009, 19 (2), 56-62.
7. Ngo, T. D.; Laeyendecker, O.; Li, C.; Tai, H.; Cui, M.; Lai, S.; Quinn, T. C. Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China. Int. J. STD. AIDS., 2008, 19 (10), 694-697.
8. Strick, L. B.; Wald, A.; Celum, C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin. Infect. Dis., 2006, 43 (3), 347-356.
9. Elion, G. B.; Furman, P. A.; Fyfe, J. A.; de Miranda, P.; Beauchamp, L.; Schaeffer, H. J. The selectivity of action of an antiherpetic agent, 9-(2- hydroxyethoxymethyl) guanine. Reproduced from Proc. Natl. Acad. Sci. USA 74, 5716-5720 (1977). Rev. Med. Virol., 1999, 9 (3), 147-152; discussion 152-153.
10. Tyring, S. K.; Douglas, J. M., Jr.; Corey, L.; Spruance, S. L.; Esmann, J. A randomized, placebo- controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch. Dermatol., 1998, 134 (2), 185-191.
11. Sacks, S. L.; Aoki, F. Y.; Diaz-Mitoma, F.; Sellors, J.; Shafran, S. D. Patientinitiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA, 1996, 276 (1), 44-49.
12. Brantley, J. S.; Hicks, L.; Sra, K.; Tyring, S. K. Valacyclovir for the treatment of genital herpes. Expert. Rev. Anti. Infect. Ther., 2006, 4 (3), 367-376.
13. Morfin, F.; Thouvenot, D. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol., 2003, 26 (1), 29-37.
14. Heldwein, E. E.; Krummenacher, C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life. Sci., 2008, 65 (11), 1653-1668.
15. Turner, A.; Bruun, B.; Minson, T.; Browne, H. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J. Virol., 1998, 72 (1), 873-875.
16. Pertel, P. E.; Fridberg, A.; Parish, M. L.; Spear, P. G. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology, 2001, 279 (1), 313-324.
17. Muggeridge, M. I. Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells. J. Gen. Virol., 2000, 81 (Pt 8), 2017-2027.
18. Kurokawa, M.; Ochiai, H.; Nagasaka, K.; Neki, M.; Xu, H.; Kadota, S.; Sutardjo, S.; Matsumoto, T.; Namba, T.; Shiraki, K. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral. Res., 1993, 22 (2-3), 175-188.
19. Cheng, C.L.; Xu, H.X. Antiviral agents from traditional Chinese medicine against herpes simplex virus. J. Trad. Med., 2005, 22(Suppl 1), 133-137.
20. Superti, F.; Ammendolia, M. G.; Marchetti, M. New advances in anti-HSV chemotherapy. Curr. Med. Chem., 2008, 15 (9), 900-911.
21. Greco, A.; Diaz, J. J.; Thouvenot, D.; Morfin, F. Novel targets for the development of anti-herpes compounds. Infect. Disord. Drug. Targets., 2007, 7 (1), 11-18.
22. Schang, L. M. Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs. Curr. Drug. Targets. Infect. Disord., 2005, 5 (1), 29-37.
23. Khan, M. T.; Ather, A.; Thompson, K. D.; Gambari, R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral. Res., 2005, 67 (2), 107-119.
24. Mukhtar, M.; Arshad, M.; Ahmad, M.; Pomerantz, R. J.; Wigdahl, B.; Parveen, Z. Antiviral potentials of medicinal plants. Virus. Res., 2008, 131 (2), 111-120.
25. Koo, M. W.; Cho, C. H. Pharmacological effects of green tea on the gastrointestinal system. Eur. J. Pharmacol., 2004, 500 (1-3), 177-185.
26. Isaacs, C. E.; Wen, G. Y.; Xu, W.; Jia, J. H.; Rohan, L.; Corbo, C.; Di Maggio, V.; Jenkins, E. C., Jr.; Hillier, S. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob. Agents. Chemother., 2008, 52 (3), 962-970.
27. Cheng, H. Y.; Lin, C. C.; Lin, T. C. Antiviral properties of prodelphinidin B- 2 3'-O-gallate from green tea leaf. Antivir. Chem. Chemother., 2002, 13 (4), 223-229.
28. Kuo, Y. C.; Kuo, Y. H.; Lin, Y. L.; Tsai, W. J. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression. Antiviral. Res., 2006, 70 (3), 112-120.
29. Cheng, H. Y.; Lin, T. C.; Yang, C. M.; Wang, K. C.; Lin, L. T.; Lin, C. C. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. J. Antimicrob. Chemother., 2004, 53 (4), 577-583.
30. Lin, C. C.; Cheng, H. Y.; Yang, C. M.; Lin, T. C. Antioxidant and antiviral activities of Euphorbia thymifolia L. J. Biomed. Sci., 2002, 9 (6 Pt 2), 656-664.
31. Yang, C. M.; Cheng, H. Y.; Lin, T. C.; Chiang, L. C.; Lin, C. C. Euphorbia thymifolia suppresses herpes simplex virus-2 infection by directly inactivating virus infectivity. Clin. Exp. Pharmacol. Physiol., 2005, 32 (5-6), 346-349.
32. Hayashi, K.; Hayashi, H.; Hiraoka, N.; Ikeshiro, Y. Inhibitory activity of soyasaponin II on virus replication in vitro. Planta. Med., 1997, 63 (2), 102-105.
33. Kinjo, J.; Yokomizo, K.; Hirakawa, T.; Shii, Y.; Nohara, T.; Uyeda, M. Antiherpes virus activity of fabaceous triterpenoidal saponins. Biol. Pharm. Bull., 2000, 23 (7), 887-889.
34. Fiore, C.; Eisenhut, M.; Krausse, R.; Ragazzi, E.; Pellati, D.; Armanini, D.; Bielenberg, J. Antiviral effects of Glycyrrhiza species. Phytother. Res., 2008, 22 (2), 141-148.
35. Sekizawa, T.; Yanagi, K.; Itoyama, Y. Glycyrrhizin increases survival of mice with herpes simplex encephalitis. Acta. Virol., 2001, 45 (1), 51-54.
36. Ikeda, T.; Yokomizo, K.; Okawa, M.; Tsuchihashi, R.; Kinjo, J.; Nohara, T.; Uyeda, M. Anti-herpes virus type 1 activity of oleanane-type triterpenoids. Biol. Pharm. Bull., 2005, 28 (9), 1779-1781.
37. Hirabayashi, K.; Iwata, S.; Matsumoto, H.; Mori, T.; Shibata, S.; Baba, M.; Ito, M.; Shigeta, S.; Nakashima, H.; Yamamoto, N. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem. Pharm. Bull., (Tokyo) 1991, 39 (1), 112-115.
38. Kuo, Y. C.; Lee, Y. C.; Leu, Y. L.; Tsai, W. J.; Chang, S. C. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice. Antiviral. Res., 2008, 80 (2), 206-212.
39. Barquero, A. A.; Alche, L. E.; Coto, C. E. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11- dihydroxymeliacarpin, a tetranortriterpenoid of natural origin. J. Gen. Virol., 2004, 85 (Pt 2), 483-493.
40. Petrera, E.; Coto, C. E. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother. Res., 2009, 23, 1771-1777.
41. Alche, L. E.; Ferek, G. A.; Meo, M.; Coto, C. E.; Maier, M. S. An antiviral meliacarpin from leaves of Melia azedarach L. Z. Naturforsch. C, 2003, 58 (3-4), 215-219.
42. Barquero, A. A.; Michelini, F. M.; Alche, L. E. 1-Cinnamoyl-3,11- dihydroxymeliacarpin is a natural bioactive compound with antiviral and nuclear factor-kappaB modulating properties. Biochem. Biophys. Res. Commun., 2006, 344 (3), 955-962.
43. Bueno, C. A.; Barquero, A. A.; Di Consoli, H.; Maier, M. S.; Alche, L. E. A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent. Virus. Res., 2009, 141 (1), 47-54.
44. Schuhmacher, A.; Reichling, J.; Schnitzler, P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine., 2003, 10 (6-7), 504-510.
45. Du, J.; He, Z. D.; Jiang, R. W.; Ye, W. C.; Xu, H. X.; But, P. P. Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry., 2003, 62 (8), 1235-1238.
46. Cheng, H. Y.; Lin, T. C.; Ishimaru, K.; Yang, C. M.; Wang, K. C.; Lin, C. C. In vitro antiviral activity of prodelphinidin B-2 3,3'-di-O-gallate from Myrica rubra. Planta. Med., 2003, 69 (10), 953-956.
47. Kuo, Y. C.; Lin, Y. L.; Liu, C. P.; Tsai, W. J. Herpes simplex virus type 1 propagation in HeLa cells interrupted by Nelumbo nucifera. J. Biomed. Sci., 2005, 12 (6), 1021-1034.
48. Chiang, L. C.; Ng, L. T.; Cheng, P. W.; Chiang, W.; Lin, C. C. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin. Exp. Pharmacol. Physiol., 2005, 32 (10), 811-816.
49. Yang, C. M.; Cheng, H. Y.; Lin, T. C.; Chiang, L. C.; Lin, C. C. Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro. Antiviral. Res., 2005, 67 (1), 24-30.
50. Yang, C. M.; Cheng, H. Y.; Lin, T. C.; Chiang, L. C.; Lin, C. C. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J. Ethnopharmacol., 2007, 110 (3), 555-558.
51. Yang, C. M.; Cheng, H. Y.; Lin, T. C.; Chiang, L. C.; Lin, C. C. Hippomanin A from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection in vitro. Phytother. Res., 2007, 21 (12), 1182-1186.
52. Li, Y.; Leung, K. T.; Yao, F.; Ooi, L. S.; Ooi, V. E. Antiviral flavans from the leaves of Pithecellobium clypearia. J. Nat. Prod., 2006, 69 (5), 833-835.
53. Chiang, L. C.; Chiang, W.; Chang, M. Y.; Ng, L. T.; Lin, C. C. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral. Res., 2002, 55 (1), 53-62.
54. Chiang, L. C.; Chiang, W.; Chang, M. Y.; Lin, C. C. In vitro cytotoxic, antiviral and immunomodulatory effects of Plantago major and Plantago asiatica. Am. J. Chin. Med., 2003, 31 (2), 225-234.
55. Gu, H.M.; Meng, Y.W.; Pu, Q. Polysaccharide from Polygonatum cyrtonema Hua against herpes simplex virus in vitro. Chin. J. Appl. Environ. Biol., 2003, 9 (1), 21-23.
56. Liu, F.; Liu, Y.; Meng, Y.; Yang, M.; He, K. Structure of polysaccharide from Polygonatum cyrtonema Hua and the antiherpetic activity of its hydrolyzed fragments. Antiviral. Res., 2004, 63 (3), 183-189.
57. Baba, M.; Snoeck, R.; Pauwels, R.; de Clercq, E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents. Chemother., 1988, 32 (11), 1742-1745.
58. Aguilar, J.S.; Rice, M; Wagner, E.K. The polysulfonated compound suramin blocks adsorption and lateral diffusion of herpes simplex virus type-1 in Vero cells. Virology., 1999, 258 (1): 141-151.
59. Nyberg, K.; Ekblad, M.; Bergstrom, T.; Freeman, C.; Parish, C. R.; Ferro, V.; Trybala, E. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral. Res., 2004, 63 (1), 15-24.
60. Docherty, J. J.; Fu, M. M.; Stiffler, B. S.; Limperos, R. J.; Pokabla, C. M.; DeLucia, A. L. Resveratrol inhibition of herpes simplex virus replication. Antiviral. Res., 1999, 43 (3), 145-55.
61. Docherty, J. J.; Smith, J. S.; Fu, M. M.; Stoner, T.; Booth, T. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral. Res., 2004, 61 (1), 19-26.
62. Faith, S. A.; Sweet, T. J.; Bailey, E.; Booth, T.; Docherty, J. J. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells. Antiviral. Res., 2006, 72 (3), 242-251.
63. Hu, S. Y. Herbal teas and populace health care in tropical China. Am. J. Chin. Med., 1997, 25 (1), 103-134.
64. Xu, H. X.; Lee, S. H.; Lee, S. F.; White, R. L.; Blay, J. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral. Res., 1999, 44 (1), 43-54.
65. Chiu, L. C.; Zhu, W.; Ooi, V. E. A polysaccharide fraction from medicinal herb Prunella vulgaris downregulates the expression of herpes simplex virus antigen in Vero cells. J. Ethnopharmacol., 2004, 93 (1), 63-68.
66. Zhang, Y.; But, P. P.; Ooi, V. E.; Xu, H. X.; Delaney, G. D.; Lee, S. H.; Lee, S. F. Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris. Antiviral. Res., 2007, 75 (3), 242-249.
67. Han, E. H.; Choi, J. H.; Hwang, Y. P.; Park, H. J.; Choi, C. Y.; Chung, Y. C.; Seo, J. K.; Jeong, H. G. Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food. Chem. Toxicol., 2009, 47 (1), 62-69.
68. Cheng, H. Y.; Lin, T. C.; Yang, C. M.; Wang, K. C.; Lin, C. C. Mechanism of action of the suppression of herpes simplex virus type 2 replication by pterocarnin A. Microbes. Infect., 2004, 6 (8), 738-744.
69. Li, Y.; Jiang, R.; Ooi, L. S.; But, P. P.; Ooi, V. E. Antiviral triterpenoids from the medicinal plant Schefflera heptaphylla. Phytother. Res., 2007, 21 (5), 466-470.
70. Ooi, L. S.; Wong, E. Y.; Chiu, L. C.; Sun, S. S.; Ooi, V. E. Antiviral and anti-proliferative glycoproteins from the rhizome of Smilax glabra Roxb (Liliaceae). Am. J. Chin. Med., 2008, 36 (1), 185-195.
71. Tanaka, T.; Ikeda, T.; Kaku, M.; Zhu, X. H.; Okawa, M.; Yokomizo, K.; Uyeda, M.; Nohara, T. A new lignan glycoside and phenylethanoid glycosides from Strobilanthes cusia BREMEK. Chem. Pharm. Bull., (Tokyo), 2004, 52 (10), 1242-1245.
72. Cheng, H. Y.; Lin, C. C.; Lin, T. C. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral. Res., 2002, 55 (3), 447-455.
73. Luo, Y.; Xu, X.; Liu, J.; Li, J.; Sun, Y.; Liu, Z.; Van Damme, E.; Balzarini, J.; Bao, J. A novel mannose-binding tuber lectin from Typhonium divaricatum (L.) Decne (family Araceae) with antiviral activity against HSV-II and anti-proliferative effect on human cancer cell lines. J. Biochem. Mol. Biol., 2007, 40 (3), 358-367.
74. Tao, J.; Hu, Q.; Yang, J.; Li, R.; Li, X.; Lu, C.; Chen, C.; Wang, L.; Shattock, R.; Ben, K. In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate. Antiviral. Res., 2007, 75 (3), 227-233.
75. Castro, M. A.; Miguel del Corral, J. M.; Gordaliza, M.; Gomez-Zurita, M. A.; de la Puente, M. L.; Betancur-Galvis, L. A.; Sierra, J.; San Feliciano, A. Synthesis, cytotoxicity and antiviral activity of podophyllotoxin analogues modified in the E-ring. Eur. J. Med. Chem., 2003, 38 (10), 899-911.
76. Gordaliza, M.; Garcia, P. A.; del Corral, J. M.; Castro, M. A.; Gomez-Zurita, M. A. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon., 2004, 44 (4), 441-459.
77. Witvrouw, M.; De Clercq, E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol., 1997, 29 (4), 497-511.
78. Nyberg, K.; Ekblad, M.; Bergstrom, T.; Freeman, C.; Parish, C. R.; Fero, V.; Trybala, E. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral. Res., 2004, 63 (1), 15-24.
79. Keller, M. J.; Tuyama, A.; Carlucci, M. J.; Herold, B. C. Topical microbicides for the prevention of genital herpes infection. J. Antimicrob. Chemother., 2005, 55 (4), 420-423.
80. Yamaji, M.; Shudo, J. Immunomodulatory roles of topical dinitrochlorobenzene treatment in Herpes simplex virus infection. Int. Immunopharmacol., 2009, 9 (7-8), 984-989.
81. das Neves, J.; Bahia, M. F. Gels as vaginal drug delivery systems. Int. J. Pharm., 2006, 318 (1-2), 1-14.
82. Leung, D. T.; Sacks, S. L. Docosanol: a topical antiviral for herpes labialis. Expert. Opin. Pharmacother., 2004, 5 (12), 2567-2571.
83. Pope, L. E.; Marcelletti, J. F.; Katz, L. R.; Katz, D. H. Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug. J. Lipid. Res., 1996, 37 (10), 2167-2178.
84. Stockfleth, E.; Beti, H.; Orasan, R.; Grigorian, F.; Mescheder, A.; Tawfik, H.; Thielert, C. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Br. J. Dermatol., 2008, 158 (6), 1329-1338.
85. Cheng, H. Y.; Lin, L. T.; Huang, H. H.; Yang, C. M.; Lin, C. C. Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro. Antiviral. Res., 2008, 77 (1), 14-19.
86. Cheng, H. Y.; Huang, H. H.; Yang, C. M.; Lin, L. T.; Lin, C. C. The in vitro anti-herpes simplex virus type-1 and type-2 activity of Long Dan Xie Gan Tan, a prescription of traditional Chinese medicine. Chemotherapy., 2008, 54 (2), 77-83.
87. Jenssen, H.; Gutteberg, T. J.; Lejon, T. Modelling the anti-herpes simplex virus activity of small cationic peptides using amino acid descriptors. J. Pept. Res., 2005, 66 (Suppl 1), 48-56.
88. Castro, M. A.; Miguel del Corral, J. M.; Gordaliza, M.; Gomez-Zurita, M. A.; de la Puente, M. L.; Betancur-Galvis, L. A.; Sierra, J.; San Feliciano, A. Synthesis, cytotoxicity and antiviral activity of podophyllotoxin analogues modified in the E-ring. Eur. J. Med. Chem., 2003, 38 (10), 899-8911.
89. Liu, S.; Knafels, J. D.; Chang, J. S.; Waszak, G. A.; Baldwin, E. T.; Deibel, M. R., Jr.; Thomsen, D. R.; Homa, F. L.; Wells, P. A.; Tory, M. C.; Poorman, R. A.; Gao, H.; Qiu, X.; Seddon, A. P. Crystal structure of the herpes simplex virus 1 DNA polymerase. J. Biol. Chem., 2006, 281 (26), 18193-18200.
90. Heldwein, E. E.; Lou, H.; Bender, F. C.; Cohen, G. H.; Eisenberg, R. J.; Harrison, S. C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science, 2006, 313 (5784), 217-220.